NNelo Trade
← Back to Market News
October 23, 2026 at 02:32 PM UTC

8-K - Bolt Biotherapeutics, Inc. (0001641281) (Filer)

Filed: 2026-10-23 AccNo: 0001193125-26-429647 Size: 12 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Official source: U.S. Securities and Exchange Commission

Official source published: October 23, 2026 at 02:31 PM UTC

Open official source